Cancer Patients And Suicide And Depression: Disease Bioinformatics
Suicide and depression is common among individuals diagnosed with cancer. Increased risk for thoughts of suicide as well as depression is most frequent a few months after diagnosis, but tend to curb with time. Risk for suicide increases with older age, being male, and severity of diagnosis, level on pain, spirituality, social structure, and inability to work. The highest incidence of suicide has been reported in patients with oral, pharyngeal, lung, and HIV positive patients with Kaposi sarcoma, however this information may not be entirely correct as individuals may not report death as suicide in these situations. Patients that are experiencing such feelings should use medications to alleviate distress and focus on symptom management. Mobilizng support for the patient as well as maintaining frequent contact and support may reduce risk for suicide.
Cancer Patients And Suicide And Depression Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Cancer Patients And Suicide And Depression below!
For more information on how to use Laverne, please read the How to Guide.
We have 2615 products for the study of Cancer Patients And Suicide And Depression that can be applied to Flow Cytometry, Chromatin Immunoprecipitation, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.